Unveiling Biomarkers for Hard-to-Diagnose Breast Tumors

For patients with rare breast tumor, the discovery of the epigenetic signature has the potential to improve treatment guidelines and outcomes.

Related Keywords

Sandra Otoole ,Ruth Pidsley ,Clare Stirzaker ,Susan Clark ,Braydon Meyer ,Cancer Epigenetics Lab ,Methylation Biomarkers Group At Garvan ,Leader Of The Cancer Epigenetic Biomarker Group ,Phyllodes Tumor Diagnosis ,Biomarkers Group ,Research Officer ,Cancer Epigenetics ,Associate Professor Clare Stirzaker ,Cancer Epigenetic Biomarker Group ,Professor Sandrao Toole ,Professor Susan Clark ,Digital Droplet ,Breast Tumor ,Breast Cancer ,World Cancer Day ,